Leveraging in-depth analyst evaluations, we have distilled key insights from expert assessments to provide a compelling outlook for XPR. Our analysts point to weakening fundamentals and unfavorable market sentiment, indicating considerable downside risk in the near term. Based on this in-depth expert analysis, we hold a highly cautious view of this stock. Our conclusion: XPR is a Strong Sell candidate.
XPR price ended at $0.002519 on 星期五, after rising 2.28%
On Feb 13, 2026 00:00, the price of XPR rose by 2.28%, climbing from $0.002329 to $0.002519 with 24h trading volume reaching $2.1M XPR.